Severe mood disorders in children, specifically bipolar disorder (BD) and severe mood dysregulation (SMD), have recently received increased attention, as researchers and clin icians acknowledge the substantial impairment and treatment needs of these populations. The BD and SMD phenotypes differ in that BD is characterized by distinct episodes of mania (and, frequently, depression), whereas SMD is characterized by severe, chronic, impairing irritability.
Introduction
Severe mood disorders in children, specifically bipolar disorder (BD) and severe mood dysregulation (SMD), have recently received increased attention, as researchers and clin icians acknowledge the substantial impairment and treatment needs of these populations. The BD and SMD phenotypes differ in that BD is characterized by distinct episodes of mania (and, frequently, depression), whereas SMD is characterized by severe, chronic, impairing irritability. 1 Importantly, however, the 2 phenotypes are similar in that both are severe pediatric mood disorders that share some neuropsychological deficits, including deficits in facial emotion labelling. Here, we used visual scan paths to compare children with BD and SMD during facial emotion labelling to explore the extent to which this shared behavioural deficit might be mediated by common abnormalities in eye gaze. We note that this approach of examining the pathophysiology of shared deficits across diagnostic categories, as well as in healthy populations, is consistent with the new Research Domain Criteria initiative of the National Institute of Mental Health. 2 Children with BD and SMD show similar behavioural deficits in facial emotion labelling: they are are less accurate in labelling facial emotions, including happy, sad, fearful and angry expressions, than healthy control children. [3] [4] [5] Behavioural deficits in facial emotion labelling can be mediated by perturbations within the neural circuit encompassing the ventral visual pathway, amygdala and ventrolateral prefrontal regions. [6] [7] [8] In both adults and children with BD, amygdala dysfunction during facial emotion processing is among the most replicated findings. [9] [10] [11] [12] [13] [14] [15] Given the associations between amygdala dysfunction and deficits in eye gaze, 16 a study of visual scan paths in individuals with BD is a logical extension of the neuroimaging literature on this illness. With regard to SMD, the neural dysfunction data are considerably more limited, although data do suggest both amygdala and parietal dysfunction. 17, 18 The examination of visual scan patterns of emotional faces has been important to elucidate precise pathophysiological mechanisms of the aberrant face labelling behaviours across psychiatric disorders. In people with autism, [19] [20] [21] [22] psychopathy 23 and schizophrenia, [24] [25] [26] [27] each in comparison with healthy controls only, eye tracking studies have revealed associations between emotion labelling deficits and decreased attention to eyes. However, few studies consider BD, and none include children. In 1 study, adults with mood disorders, including BD, compared with those with schizophrenia or no illness, exhibited fewer and shorter fixations on facial features (i.e., eyes, noses, mouths) across emotional facial expressions and degraded faces. 28 Another study suggested that manic adults avoided looking at eyes during virtual social interactions. 29 The only other relevant study found no scan path differences between healthy adults and those with BD. 30 No prior eye movement study has attempted to differentiate healthy children from those with BD and SMD.
We tested the hypothesis that, across emotions, children with BD and SMD are less accurate than healthy children in facial emotion labelling and pay less attention to eye regions. Prior work found that children with BD and SMD manifested similar behavioural deficits resulting from different pathophysiology. Therefore, we expected disordercommon deficits in facial emotion labelling to reflect eye gaze patterns that are disorder-specific. However, because this is, to our knowledge, the first study of eye gaze in children with BD or SMD, no data exist to support specific hypotheses on the nature of these disorder-specific patterns. Thus, we used conservative statistical approaches, well protected against type 1 error, to test for between-group differences by comparing 3 groups in 3-way interaction omnibus statistical tests.
Methods

Participants
The children (ages 8-18 yr) enrolled in an Institutional Review Board-approved protocol at the National Institute of Mental Health. Parents and children provided written informed consent and assent, respectively. We recruited children with BD and SMD through advertisements posted on support groups' websites and distributed to psychiatrists nationwide. Healthy control children were recruited by local advertisement.
All children were assessed with the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL). 31 Clinicians administered the K-SADS-PL, including a module for SMD, separately to children and parents, with established inter-rater reliability, κ ≥ 0.9 for all diagnoses, including the differentiation of BD from SMD. 32 All of the interviewing staff members were graduate-level (masters or doctoral) clinicians who had received extensive training. The final diagnosis was generated using a best-estimate procedure 33 with a consensus conference chaired by a psych iatrist with extensive experience evaluating children with SMD and BD that included discussion with the interviewing clinicians and review of medical records where appropriate.
To be included in the study, children with BD had to meet the criteria for "narrow phenotype," 32 with at least 1 full-duration (hypo)manic episode characterized by abnormally elevated mood and at least 3 DSM-IV-TR "B" mania symptoms. Children with SMD had to have nonepisodic irritability, characterized by an angry mood at least half the day on most days and noticeable by others; over-reactivity to negative emotional stimuli 3 times a week or more; and hyperarousal (≥ 3 of insomnia, intrusiveness, pressured speech, flight of ideas/racing thoughts, distractibility, psycho motor agitation). 32 Symptoms of SMD must have begun before age 12 years, must have occurred for 1 year or more without remission exceeding 2 months, and must have caused severe impairment in at least 1 setting (i.e., home, school, peers) and mild impairment in another. Those with euphoric mood or distinct (hypo)manic episodes lasting 1 day or more were excluded.
For patients with BD and SMD, we assessed mood state within 48 hours of the eye-tracking session. Depressive symptoms were assessed in both groups using the Children's Depression Rating Scale (CDRS). 34 Manic symptoms were assessed in children with BD using the Young Mania Rating Scale (YMRS). 35 To evaluate symptom severity, clinicians administered the Clinical Global Impression for bipolar illness (CGI-BP) 36 for the patients with BD. For those with SMD, the Clinical Global Impression for SMD (CGI-SMD) was adapted to assess associated symptoms.
Healthy control children were medication-free, had no lifetime psychiatric diagnoses and no first-degree relatives with a mood disorder. All participants had an IQ greater than 70 (determined by the Wechsler Abbreviated Scale of Intelligence 37 ), with no history of neurologic disorder, pervasive developmental disorder, chronic medical illness or substance abuse/dependence.
Stimuli
Stimuli consisted of 130 black and white photographs of 4 facial emotions (happiness, sadness, anger, fear) and a neutral facial expression, taken from the Picture of Facial Affect set. 38 There were 10 exemplars: 6 female and 4 male. Each emotional face was morphed with a neutral face from the same exemplar, so that each emotion had 3 emotional levels: 60% (40% neutral), 80% (20% neutral) and 100% (0% neutral; prototypic expressions).
Eye tracking
Eye movements were measured with the EyeLink II headmounted, video-based eye tracker (SR Research). Eye movements were sampled at 500 Hz. Before each experiment, both eyes were calibrated and validated using 9-point calibration sequences. Calibration was repeated when maximum error at validation was more than 1.5°; 39 however, average error was below 1° in all 3 groups, and there was no group difference in the mean calibration error (p > 0.10). During the experiment, we performed drift correction every 5 trials. Fixations were defined with the default settings of EyeLink II, including a velocity threshold of 30°/s, acceleration threshold of 8000°/s 2 and distance threshold of greater than 0.1°.
Procedure
After calibration, each participant received task instructions and performed 10 practice trials. Faces presented in the practice trials were excluded from the main task. Participants repeated the 10 practice trials until they understood the task instructions.
During the task, each face appeared for 2000 ms, followed by a 3000 ms response period. During the response period, 5 words (1 = happy, 2 = angry, 3 = fearful, 4 = sad, 5 = neutral) were presented on the screen. To identify the face emotion, participants pressed a button on a 5-button box using the right hand. A blank screen appeared during the interstimulus interval (range 800-1800 ms). We used a blank screen instead of a fixation cross to avoid any experimental bias that might be introduced by a fixed starting position of the eyes before face presentation. 40 Each of the 130 faces was presented once and the total duration of the task was approxi mately 15 minutes.
Statistical analysis
Behavioural data
We compared accuracy among the groups with 2 omnibus analyses, with age as a covariate, using IBM SPSS Statistics version 19.0. First, accuracy was compared with a 3-way repeated-measures analysis of covariance (ANCOVA), with group (BD, SMD, control) as a between-subjects factor and emotion (anger, fear, sadness, happiness) and emotional level (60%, 80%, 100%) as within-subjects factors. Second, since neutral expressions had only 1 emotional level (100%), we included neutral faces in a 2-way repeatedmeasures ANCOVA with group (BD, SMD, control) as a between-subjects factor and emotion (100% level expression of anger, fear, sadness, happiness, neutral) as a withinsubjects factor. Hereafter, we refer to this analysis as the 2-way 100%-level omnibus analysis. We performed post hoc univariate ANCOVAs to decompose all significant inter actions and main effects. Only main effects and interactions that involve group differences are discussed here; other findings are included in supplemental materials (Appendix, available at cma.ca/jpn; for all results, see Table  S1 ). Age differed among the groups (F 2,69 = 3.18, p < 0.05) and was included as a covariate in all analyses. Because responses were made during the response period after the face disappeared, reaction time did not necessarily reflect individual differences validly, and reaction times were therefore not compared among participants.
Eye movement data
The 3 primary eye movement variables (total duration of fixations, number of fixations, average fixation duration) in each of 3 interest areas (eyes, nose and mouth) were calculated using EyeLink Data Viewer software (SR Research). We performed subsequent analyses with IBM SPSS Statistics version 19.0.
As with the behavioural data, we conducted 2 omnibus ANCOVA analyses for each variable, with age as a covariate. First, a 4-way repeated-measures ANCOVA included group (BD, SMD, control) as a between-subjects factor and emotion (anger, fear, sadness, happiness), emotional level (60%, 80%, 100%) and interest areas (eyes, nose, mouth) as within-subjects factors. Second, because the neutral expression had only 1 level of emotion (100%), a separate omnibus analysis compared outcome variables for only 100%-level expressions, including neutral. This 3-way repeatedmeasures ANCOVA included group (BD, SMD, control) as a between-subjects factor, and emotion (100% emotional expression of anger, fear, sadness, happiness, neutral) and interest areas (eyes, nose, mouth) as within-subjects factors. Hereafter, we refer to this analysis as the 3-way 100%-level omnibus analysis.
All significant interactions and main effects were decomposed by post hoc ANCOVA analyses. However, because group differences are the primary focus of this paper, we present and discuss only interactions and main effects involving between-group differences; other findings are included in the Appendix (for all results, see Tables S2-S4) . In each group, we examined associations between accuracy and eye movement data with bivariate Pearson correlations. The Fisher z transformation was used to assess the significance of the differences in correlation coefficients among the groups. In addition, we used bivariate Pearson correlations to explore associations between eye movement data and clinical measures. In children with BD, eye movement data correlated with YMRS, CDRS, CGI-BP Depression or CGI-BP Mania scores. In children with SMD, eye movement data were correlated with CDRS and overall CGI-SMD scores. Finally, we conducted post hoc exploratory univariate ANCOVAs to test potentially confounding effects of comorbid illnesses, mood state or medications on the eye movement findings (see the Appendix for details).
Results
Demographic and clinical characteristics
We enrolled 72 participants: 22 children with BD, 28 children with SMD and 22 healthy controls. Groups did not differ in sex, race or IQ (all p > 0.10). On average, children with BD were older than those with SMD (p = 0.018) and controls (p = 0.07; Table 1 ), thus age was included as a covariate in all analyses.
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J Psychiatry Neurosci 2013;38(6) Children with BD were more likely to be taking lithium than those with SMD (p = 0.004). Conversely, children with SMD were more likely to be euthymic (p = 0.003) and to have comorbid oppositional defiant disorder (ODD) or other conduct disorders than those with BD (p = 0.035; Table 1 ).
Emotion labelling accuracy
No 3-way or 2-way interactions were found in either of the omnibus ANCOVA analyses. We found a main effect of group in both the 3-way omnibus (F 2,68 = 3.81, p = 0.027) and the 2-way 100%-level omnibus (F 2,68 = 4.54, p = 0.014) analyses. Post hoc analyses indicated that children with SMD were less accurate than controls in both analyses (all F 1,47 > 5.92, all p < 0.019). Children with BD were also less accurate than controls in the 2-way 100%-level analysis (F 1,41 = 8.96, p = 0.005), with a similar trend in the 3-way analysis (F 1,41 = 3.00, p = 0.09; Fig. 1 ).
Eye movement data
Total fixation durations
In the 4-way omnibus ANCOVA, a group × interest areas × emotional level interaction was significant (F 8,272 = 2.15, p = 0.032). Post hoc analyses revealed that children with BD spent significantly less time than controls fixating on eyes for all emotional levels, regardless of specific facial emotion (all Fig. 2A-C) . Children with SMD also spent less time than controls fixating on eyes, but this was only significant at 80% morphed and 100% emotional expressions across all emotions (all F 1,48 > 2.85, all p < 0.10; Fig. 2BC ). In all 80% morphed emotional expressions, children with BD spent more time than controls fixating on the nose (F 1,41 = 7.01, p = 0.011; Fig. 2B ). No other group differences were found in fixations on the nose or mouth.
In the 3-way 100%-level omnibus ANCOVA analysis, a group × interest areas interaction emerged (F 4,136 = 3.13, p = 0.017). Post hoc analyses were consistent with the 4-way omnibus analysis. Specifically, across emotions, children with BD spent less time fixating on eyes than controls (F 1,41 = 8.57, p = 0.006) or children with SMD (F 1,48 = 2.87, p = 0.10).
Therefore, across all 5 emotional expressions, children with BD spent less time than controls fixating on eyes. For some expressions, children with SMD also spent less time than controls fixating on eyes (Fig. 2) .
Number of fixations
In the 4-way omnibus analysis, a group × interest areas × emotion interaction emerged (F 12,408 = 2.11, p = 0.015). Post hoc analyses indicated that, for all emotional expressions, children with BD made fewer fixations than controls on eyes (all F 1,41 > 13.32, all p < 0.001; Fig. 3A-D) . For angry expressions only, children with BD tended to make fewer fixations than those with SMD on eyes (all F 1,47 > 3.43, all p < 0.07; Fig. 3A) .
Similarly, in the 3-way 100%-level omnibus ANCOVA, the group × interest areas interaction was significant (F 4,136 = 3.66, p = 0.007), indicating that, regardless of specific facial emotion, children with BD made fewer fixations on eyes than controls (F 1,41 = 15.50, p = 0.001) or children with SMD (F 1,47 = 3.30, p = 0.08). When neutral expression was analyzed separately, findings were consistent with those for other emotions: children with BD made fewer fixations on eyes than controls (F 1,41 = 13.75, p = 0.001) or children with SMD (F 1,47 = 4.13, p = 0.048; Fig. 3E) .
Therefore, across all emotions, children with BD made fewer fixations on eyes than controls, and the number of eye fixations made by children with SMD fell between those of children with BD and controls (Fig. 4) .
Mean fixation duration
In both 4-way and 3-way 100%-level omnibus ANCOVA analysis, there were no interactions and no main effect of group.
Associations between emotion labelling accuracy and fixation patterns
We examined whether fixations on the eyes were associated with emotion labelling accuracy in each group. First, we examined the correlation between accuracy and the number of eye fixations across expressions. We found a significant correlation in children with BD (r 22 children with BD and those with SMD showed a trend difference (Fisher z = 1.46, p = 0.07, 1-tailed), but those of children with SMD did not differ from those of controls. Second, we examined the association between total duration of fixations on the eyes and accuracy. The correlation between accuracy and total time fixated on eyes was a trend in children with BD (r 22 = 0.37, p = 0.09), but not in those with SMD (r 22 = 0.02) or in controls (r 22 = -0.15). The Fisher z test revealed that the correlation coefficients of children with BD and controls differed (Fisher z = 1.66, p = 0.049, 1-tailed) . Those of children with BD versus SMD or of SMD versus controls did not differ.
Thus, decreased attention to eyes was associated with lower accuracy in emotion labelling in children with BD (Fig. 5) , but not in those with SMD or in controls.
Associations between fixation patterns and clinical measures
Among children with SMD, overall symptom severity, as measured by the CGI-SMD, was positively associated with both total duration of mouth fixations (r 28 
Effects of mood state, medication or comorbid illnesses
Post hoc exploratory analyses examined whether gaze pattern differences between children with BD and controls could be driven by comorbid illnesses, mood state or medications (see the Appendix for details). The differences in total fixation durations and mean number of fixations between children with BD and controls largely remained significant at a trend level or better, even after controlling for comorbid illnesses and mood states (all p < 0.06). Since the number of unmedicated children with BD was very small (n = 3), we were unable to test for confounding effects of medication. The difference in total fixation duration on eyes of 80% morphed emotional expressions between children with SMD and controls was significant when the analysis was limited to unmedicated children (p = 0.009), but not when effects of cooccurring illnesses were tested. 
Discussion
We examined the gaze patterns of children with BD or SMD during a face emotion labelling task to examine whether dysfunctional gaze patterns contribute to the previously observed emotion labelling deficits in these populations. Consistent with the results of previous studies, 3,14 across emotions, children with BD and those with SMD were less accurate than healthy children in identifying facial emotions. As hypothesized, children with BD exhibited reduced attention to eyes; they spent less time fixating on eyes and made fewer eye fixations than controls across emotions. Gaze patterns in children with SMD tended to fall between those of children with BD and controls. Increased eyes fixations were associated with increased accuracy across emotions only in children with BD. To our knowledge, this is the first study to demonstrate that reduced attention to eyes is associated with emotion labelling deficits in children with BD. Although children with SMD exhibited some abnormal gaze patterns, they were limited to specific conditions.
Our findings in children with BD were particularly clear: they showed decreased attention to eyes (compared with controls) in all emotional expressions. Furthermore, among children with BD, decreased attention to eyes was associated with lower accuracy in emotion labelling across emotions. This is consistent with the observation that when gathering emotional information the most effective visual scanning strategies involve attending to eyes. 42 We did not observe a similar association among controls. Perhaps 1 or 2 fixations are sufficient for accurate labelling in controls, 43 whereas children with BD require more fixations. Similar findings have been reported previously: greater attention to the eye region was associated with increased accuracy of fear labelling in children with severe psychopathic traits, but not in children with mild psychopathic traits. 23 Our findings in children with SMD were less clear than those in children with BD. Like children with BD, those with SMD were less accurate than controls when labelling emotional expressions. Visual attention to eyes among children with SMD fell consistently between that among children with BD and controls, and on most measures, children with SMD did not differ from those with BD or controls. These equivocal findings in children with SMD should prompt further study. Comorbid attention-deficit/hyperactivity disorder (ADHD) may contribute to the gaze patterns in children with SMD. Given that the SMD criteria required hyperarousal symptoms that overlap with ADHD, the latter is a common comorbid disorder in children with SMD. 44 Evidence is mixed about whether children with ADHD are less accurate than healthy individuals and exhibit neural abnormalities during facial emotion labelling. 3, 18, [45] [46] [47] The only existing study of gaze patterns during facial emotion labelling in an ADHD population showed that adult patients made more fixations of shorter dur ations across facial features than healthy adults, 48 which is distinct from the pattern we observed in the present study. However, more work in a larger sample is needed to dissociate the effects of chronic irritability from those of comorbid ADHD on gaze patterns during face processing.
Emotion labelling recruits several brain regions, including the amygdala, ventral visual pathway (including fusiform gyrus) and ventrolateral prefrontal cortex (VLPFC). [6] [7] [8] The aberrant gaze patterns we observed in children with BD may reflect abnormalities in these regions. For example, the amygdala plays a role in directing attention to eye regions during facial emotion processing, 16, 39, 49 and amygdala hyperactivity is associated with decreased attention to eye regions in children with a history of early deprivation 50 and in adults with schizophrenia 24 or social anxiety disorder. 51 Amygdala hyperactivity has been reported consistently in individuals with BD during facial emotion processing. 9, 10, 13, 14 In children and adults with BD, VLPFC hypoactivity in response to emotional stimuli is also well documented. 12, 13 Therefore, the reduced attention to eye regions that we observed in children with BD may be associated with amygdala and VLPFC dysfunction.
Literature on neural abnormalities in people with SMD has been limited and inconsistent. One study reported decreased amygdala responses in individuals with SMD compared with both controls and individuals with BD during fear rating of neutral faces. 18 Another study demonstrated that, while participants with BD and SMD exhibited similar deficits in amyg dala modulation in response to facial expressions of increasing anger intensity, the 2 patient groups exhibited different patterns of abnormalities in ventral visual pathway and frontoparietal activity. 17 Future work combining functional magnetic resonance imaging and eye tracking is needed to elucidate associations among neural dysfunction, impaired eye gaze and facial emotion labelling deficits in children with BD and SMD.
The present study may provide evidence to support abnormal gaze patterns as a biomarker of a potential endophenotype for emotion labelling deficits in patients with BD and in those with SMD. Moreover, the fact that gaze patterns in children with SMD fell between those of children with BD and controls may suggest that such an endophenotype is on a continuum and is state-dependent. In the present study, there was an association between gaze pattern and current symptom severity in children with SMD, but not in those with BD. Thus, abnormal eye gaze during facial emotion processing may be influenced by clinical state in individuals with SMD. Although current symptom severity was not associated with gaze patterns in children with BD, a potentially more restricted range of symptom severity in these children may preclude a similar association between symptom severity and gaze patterns.
Gaze pattern abnormalities in individuals with BD and SMD should also be considered in light of similar abnormalities observed in individuals with other psychiatric disorders. Social cognition deficits have also been suggested as a potential endophenotype for schizophrenia 24, 52 and anxiety disorders. 53 Several lines of research, particularly molecular genetics, suggest pathophysiological links between BD and schizophrenia. With regard to SMD, childhood irritability predicts anxiety disorders and depression in adulthood. 54, 55 Therefore, abnormal gaze patterns associated with childhood irritability may be a biomarker of the increased risk for anxiety disorders developing in adulthood. Thus, our findings are consistent with the growing trend in psychiatric research to acknowledge shared pathophysiological links across diagnoses previously considered distinct. Paranoid delusions during mania may be associated with aberrant gaze patterns in individuals with BD. Studies suggest that paranoid delusions are associated with decreased attention to threatening cues in a scene. 56, 57 In the present study, no child with BD was manic at the time of the study. However, the fewer and shorter fixations on eyes that we observed in the children with BD may become more severe during manic states with paranoid delusions. Therefore, studies including a larger sample of children with BD are needed to examine associations between eye gaze and different mood states.
Limitations
Although the findings from the present study are promising, some limitations are worth noting. First, most children with BD were medicated, and the BD sample was heterogeneous in mood state and comorbid diagnoses. Post hoc analyses suggest that decreased attention to eyes among children with BD was largely unrelated to this clinical heterogeneity, although we were unable to assess the role of medication owing to insufficient numbers of unmedicated patients with BD. Second, although children with BD and SMD exhibited similar rates of comorbid ADHD and anxiety disorders, the 2 groups differed in the rate of ODD. Children with SMD had a higher rate of comorbid ODD because criteria for ODD include nonepisodic irritability symptoms, such as "often loses temper" and "is often touchy and easily annoyed by others." However, our post hoc analysis comparing children with SMD but without ODD or other conduct disorders and healthy controls revealed that comorbid ODD status did not drive the gaze pattern differences that we identified between children with SMD and controls. Third, we do not have data to test whether decreased attention to eyes is related to social functioning in children with BD and SMD; this is worthy of investigation. Fourth, our findings differ from those of a previous study in which adults with BD did not exhibit abnormal gaze patterns during face scanning. 30 While deficits in facial emotion labelling are present in both adults and children with BD, evidence suggests that these abnormalities may be more consistent and marked in children 11, 58 and may result in measurable eye gaze impairments. Future work comparing gaze patterns and facial emotion labelling deficits in pediatric and adult BD is important to better understand developmental differences. Fifth, the present study included children across a wide age span from childhood to adolescence. The limited sample size does not allow us to examine associations between age and eye gaze abnormalities. However, given the literature about prefrontal cortical development in adolescence, 59 future studies should examine associations among age, prefrontal cortex function, emotion labelling deficits and eye gaze in these patient groups. Last, group differences in socioeconomic status or race may influence eye gaze patterns. There was no difference in race ratio among the groups, but we did not obtain information on participants' socioeconomic status. Future studies should examine the effects of socioeconomic status on eye gaze in individuals with BD and SMD.
Conclusion
The present study demonstrated the associations between facial emotion labelling deficits and impaired attention to eyes in children with BD. Gaze patterns in children with SMD tended to fall between those of children with BD and healthy controls. The link between decreased attention to eyes and emotion labelling accuracy in children with BD may have clinical implications. It suggests that teaching patients to look at eyes while processing emotional expressions may help improve their ability to recognize facial expressions. Previous studies demonstrate that instructing individuals with emotion labelling deficits to focus on eyes improved their ability to identify emotions correctly, 16, 23 suggesting possible future interventions in children with BD.
